{"id":386896,"date":"2016-03-23T00:00:00","date_gmt":"2016-03-23T00:00:00","guid":{"rendered":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/m360bt0003-medtech-therapeutic-botulinum-toxin-global-2016-market-analysis\/"},"modified":"2026-03-31T10:20:11","modified_gmt":"2026-03-31T10:20:11","slug":"m360bt0003-medtech-therapeutic-botulinum-toxin-global-2016-market-analysis","status":"publish","type":"report","link":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/m360bt0003-medtech-therapeutic-botulinum-toxin-global-2016-market-analysis\/","title":{"rendered":"Therapeutic Botulinum Toxin | Global | 2016 | Market Analysis"},"content":{"rendered":"<p>The global therapeutic\u00a0<abbr title=\"Botulinum Toxin\">BTX<\/abbr>\u00a0market will grow strongly through 2024, with newly approved indications, the need for repeat\u00a0<abbr title=\"Botulinum Toxin\">BTX<\/abbr>\u00a0treatments, and a largely favorable reimbursement environment driving significant procedure volume and unit sales expansion.<\/p>\n<p>This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for therapeutic\u00a0<abbr title=\"Botulinum Toxin\">BTX<\/abbr>\u00a0in the US, France, Germany, Italy, Spain, the UK, and Japan\u00a0across a 10-year period.<\/p>\n<p>\u00a0<\/p>\n<p><b>New indication approvals will be significant drivers in the therapeutic\u00a0<abbr title=\"Botulinum Toxin\">BTX<\/abbr>\u00a0market.<\/b><\/p>\n<p>Which indications contribute the most to growth?<\/p>\n<p>What regional differences exist regarding indication approvals?<\/p>\n<p>What new indications have the largest market potential?<\/p>\n<p><strong>The global therapeutic markets are becoming more and more consolidated.<\/strong><\/p>\n<p>What are some key competitive strategies being employed to succeed in the market?<\/p>\n<p>How do the competitive landscapes differ by region, and what considerations must companies make in particular markets?<\/p>\n<p><b>Markets vary greatly by region in terms of size and growth,\u00a0<\/b><strong>with the Japanese market experiencing the fastest growth globally.<\/strong><\/p>\n<p>What key drivers contribute to a market&#8217;s relative size and growth?<\/p>\n<p>What factors most significantly affect pricing within markets?<\/p>\n<p><b>Emerging products could have significant impact on the\u00a0<abbr title=\"Botulinum Toxin\">BTX<\/abbr>\u00a0market.<\/b><\/p>\n<p>Will emerging products expand on or compete against the existing\u00a0<abbr title=\"Botulinum Toxin\">BTX<\/abbr>\u00a0market?<\/p>\n<p>What are some potential competitive advantages emerging products might have?<\/p>\n","protected":false},"template":"","class_list":["post-386896","report","type-report","status-publish","hentry","report-gateway-medtech","medtech-therapy-area-therapeutic-botulinum-toxin","medtech-date-857"],"acf":[],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/386896","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report"}],"about":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/types\/report"}],"version-history":[{"count":1,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/386896\/revisions"}],"predecessor-version":[{"id":388391,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/386896\/revisions\/388391"}],"wp:attachment":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/media?parent=386896"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}